Sign in
4

Changes in Ownership

Inhibikase Therapeutics, Inc. Filed Acc 0000950170-25-007742

Options or other derivatives

  • Director acquired 70,106 shares (grant or award)
  • Director returned 70,106 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Freeman Roy Lester Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −21,854 0 D: show line 1 in the form
Freeman Roy Lester Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +21,854 21,854 D: show line 2 in the form
Freeman Roy Lester Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −1,138 0 D: show line 3 in the form
Freeman Roy Lester Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +1,138 1,138 D: show line 4 in the form
Freeman Roy Lester Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −3,780 0 D: show line 5 in the form
Freeman Roy Lester Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +3,780 3,780 D: show line 6 in the form
Freeman Roy Lester Director 2025-01-21 Returned to the company · Stock Option (Right to Buy) −6,667 0 D: show line 7 in the form
Freeman Roy Lester Director 2025-01-21 Grant or award · Stock Option (Right to Buy) +6,667 6,667 D: show line 8 in the form
Loading xslF345X05/ownership.xml…